These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 16166454

  • 1. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
    Mohanty S, Huang J, Basu A.
    Clin Cancer Res; 2005 Sep 15; 11(18):6730-7. PubMed ID: 16166454
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin resistance is associated with deregulation in protein kinase C-delta.
    Huang J, Mohanty S, Basu A.
    Biochem Biophys Res Commun; 2004 Apr 16; 316(4):1002-8. PubMed ID: 15044084
    [Abstract] [Full Text] [Related]

  • 3. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
    Basu A, Lazo JS.
    Cancer Res; 1992 Jun 01; 52(11):3119-24. PubMed ID: 1591725
    [Abstract] [Full Text] [Related]

  • 4. The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1.
    Lorenzo PS, Bögi K, Acs P, Pettit GR, Blumberg PM.
    J Biol Chem; 1997 Dec 26; 272(52):33338-43. PubMed ID: 9407126
    [Abstract] [Full Text] [Related]

  • 5. Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C.
    Basu A, Akkaraju GR.
    Biochemistry; 1999 Apr 06; 38(14):4245-51. PubMed ID: 10194341
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A, Weixel K, Saijo N.
    Cell Growth Differ; 1996 Nov 06; 7(11):1507-12. PubMed ID: 8930400
    [Abstract] [Full Text] [Related]

  • 7. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
    Gschwend JE, Fair WR, Powell CT.
    Mol Pharmacol; 2000 Jun 06; 57(6):1224-34. PubMed ID: 10825394
    [Abstract] [Full Text] [Related]

  • 8. Differential effect of bryostatin 1 and phorbol 12-myristate 13-acetate on HOP-92 cell proliferation is mediated by down-regulation of protein kinase Cdelta.
    Choi SH, Hyman T, Blumberg PM.
    Cancer Res; 2006 Jul 15; 66(14):7261-9. PubMed ID: 16849575
    [Abstract] [Full Text] [Related]

  • 9. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
    Le XF, Marcelli M, McWatters A, Nan B, Mills GB, O'Brian CA, Bast RC.
    Oncogene; 2001 Dec 13; 20(57):8258-69. PubMed ID: 11781840
    [Abstract] [Full Text] [Related]

  • 10. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
    Lorenzo PS, Bögi K, Hughes KM, Beheshti M, Bhattacharyya D, Garfield SH, Pettit GR, Blumberg PM.
    Cancer Res; 1999 Dec 15; 59(24):6137-44. PubMed ID: 10626804
    [Abstract] [Full Text] [Related]

  • 11. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM.
    Mol Pharmacol; 1994 Nov 15; 46(5):840-50. PubMed ID: 7969070
    [Abstract] [Full Text] [Related]

  • 12. Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta.
    Basu A, Tu H.
    Biochem Biophys Res Commun; 2005 Sep 09; 334(4):1068-73. PubMed ID: 16039614
    [Abstract] [Full Text] [Related]

  • 13. Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.
    von Burstin VA, Xiao L, Kazanietz MG.
    Mol Pharmacol; 2010 Sep 09; 78(3):325-32. PubMed ID: 20516369
    [Abstract] [Full Text] [Related]

  • 14. Involvement of protein kinase C-delta in DNA damage-induced apoptosis.
    Basu A, Woolard MD, Johnson CL.
    Cell Death Differ; 2001 Sep 09; 8(9):899-908. PubMed ID: 11526445
    [Abstract] [Full Text] [Related]

  • 15. Involvement of proteolytic activation of PKCdelta in cisplatin-induced apoptosis in human small cell lung cancer H69 cells.
    Persaud SD, Hoang V, Huang J, Basu A.
    Int J Oncol; 2005 Jul 09; 27(1):149-54. PubMed ID: 15942654
    [Abstract] [Full Text] [Related]

  • 16. Regulation of p53 stabilization by DNA damage and protein kinase C.
    Johnson CL, Lu D, Huang J, Basu A.
    Mol Cancer Ther; 2002 Aug 09; 1(10):861-7. PubMed ID: 12492119
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of PKCepsilon sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1.
    Powell CT, Yin L.
    Int J Cancer; 2006 Mar 15; 118(6):1572-6. PubMed ID: 16184549
    [Abstract] [Full Text] [Related]

  • 18. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.
    Basu A.
    Mol Pharmacol; 1998 Jan 15; 53(1):105-11. PubMed ID: 9443937
    [Abstract] [Full Text] [Related]

  • 19. Differential regulation of extrinsic and intrinsic cell death pathways by protein kinase C.
    Basu A, Miura A.
    Int J Mol Med; 2002 Nov 15; 10(5):541-5. PubMed ID: 12373288
    [Abstract] [Full Text] [Related]

  • 20. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
    Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE.
    Clin Cancer Res; 1995 Dec 15; 1(12):1581-7. PubMed ID: 9815959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.